Australia's EMVision Medical Devices rises on positive trial data

EMvision Medical Devices

27/05/2024 05:16

** Shares of EMVision Medical Devices  EMV.AX  rise as much
as 9.42% to A$2.09, their highest level since May 8
    ** Stock on track for best day since March 13, if gains hold
    ** Medical device maker says its latest clinical trial data
confirms that its AI algorithm has potential to identify
patterns and features across complex ischaemic patient data
sets, including early onset of hyperacute ischaemic stroke
    ** Ischaemic stroke refers to a medical emergency caused by
blockage in a blood vessel that supplies blood to a region of
the brain
    ** 84,966 shares changed hands by 0410 GMT, 1.4 times the
30-day average volume of shares
    ** Stock has risen 12.68% this year, as of last close

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))